About 1 result found for searched term "Ladarixin sodium" (0.098 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M30746 | Ladarixin sodium | CXCR |
| DF 2156A | ||
| Ladarixin sodium (DF 2156A) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin sodium can be used for the research of COPD and asthma. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.